Lv513
1280 积分 2025-08-27 加入
Lutetium-177 [177Lu]Lu-PSMA-I&T plus radium-223 in patients with metastatic castration-resistant prostate cancer (AlphaBet): an interim analysis of the investigator-initiated, single-centre, single-arm, phase 1/2 trial
24天前
已完结
Toxicities of radioligand and radioisotope therapy in prostate cancer: a systematic review and meta-analysis
24天前
已关闭
Clinical Translation of Targeted α-Therapy: An Evolution or a Revolution?
24天前
已完结
Adverse reactions to therapeutic radiopharmaceuticals
25天前
已完结
Efficacy and Safety of Oncolytic Viruses Immunotherapy in Advanced Malignancies
28天前
已完结
Repurposing antitumor drugs for the treatment of non-oncological diseases: Mechanistic insights, clinical evidence, and future perspectives
5个月前
已完结
First-line zorifertinib for EGFR-mutant non-small cell lung cancer with central nervous system metastases: The phase 3 EVEREST trial
6个月前
已完结
Activation of the AKT and STAT3 pathways and prolonged survival by a mutant EGFR in human lung cancer cells
6个月前
已完结
[Non-small cell lung cancer in adults under 40 years of age]
6个月前
已关闭
Comparing the Effectiveness and Safety of First-line Interventions in Patients With Advanced Epidermal Growth Factor Receptor-mutant Non-small Cell Lung Cancer, With Particular Focus on Brain Metastatic Status: A Systematic Review and Network Meta-analysis
6个月前
已完结
皖公网安备34019202002308
